Sean McCutcheon Stock Analyst Profile - Raymond James Research Coverage - Stocknear

Sean McCutcheon

Stock Analyst at Raymond James

(3.11)
# 2935
Out of 5,506 analysts
10
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

9 Stocks

Name Action PT Current % Upside Ratings Updated
RVMD Revolution Medicines
Assumes: Strong Buy
72
46.71 54.14% 1 Sep 12, 2025
VIR Vir Biotechnology
Initiates Coverage On: Outperform
12
5.73 109.42% 1 Jul 11, 2025
JANX Janux Therapeutics
Initiates Coverage On: Outperform
65
24 170.83% 1 Jul 11, 2025
CMPX Compass Therapeutics
Reinstates: Outperform
9
3.7 143.24% 1 Jul 1, 2025
BDTX Black Diamond Therap...
Reinstates: Outperform
11
3.89 182.78% 1 Jul 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
23
7.75 196.77% 1 Nov 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
58 40
11.77 239.85% 1 Jun 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
92 70
56.97 22.87% 2 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
86
32.06 168.25% 1 Mar 13, 2024